BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17203161)

  • 1. Expression of the Endothelin-axis in the different histologic subtypes of renal cell carcinoma: a tissue microarray analysis.
    Herrmann E; Eltze E; Bierer S; Bogemann M; Brinkmann OA; Balnowair H; Hertle L; Wulfing C
    Oncol Rep; 2007 Feb; 17(2):275-80. PubMed ID: 17203161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic relevance of endothelin-B receptor in vulvar cancer.
    Eltze E; Bertolin M; Korsching E; Wülfing P; Maggino T; Lellé R
    Oncol Rep; 2007 Aug; 18(2):305-11. PubMed ID: 17611649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis.
    Herrmann E; Bögemann M; Bierer S; Eltze E; Toma MI; Köpke T; Hertle L; Wülfing C
    Oncol Rep; 2007 Jul; 18(1):133-8. PubMed ID: 17549358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt-chloride induced hypoxia.
    Wülfing P; Götte M; Sonntag B; Kersting C; Schmidt H; Wülfing C; Buerger H; Greb R; Böcker W; Kiesel L
    Int J Oncol; 2005 Apr; 26(4):951-60. PubMed ID: 15753989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance between expression of endothelin receptors A and B in terminal liver cirrhosis due to hepatitis C viral infection: immunohistochemical study of autopsy cases.
    Kitamura Y; Hayashi K
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e451-6. PubMed ID: 17565586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the endothelin axis in bladder cancer: relationship to clinicopathologic parameters and long-term survival.
    Wülfing C; Eltze E; Yamini J; Wülfing P; Bierer S; Böcker W; Hertle L; Semjonow A; Sievert KD
    Eur Urol; 2005 May; 47(5):593-600. PubMed ID: 15826749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1, Endothelin-A- and Endothelin-B-receptor expression in preinvasive and invasive breast disease.
    Wülfing P; Diallo R; Kersting C; Wülfing C; Poremba C; Greb RR; Böcker W; Kiesel L
    Oncol Rep; 2004 Apr; 11(4):791-6. PubMed ID: 15010874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered endothelin receptor subtypes in colorectal cancer.
    Hoosein MM; Dashwood MR; Dawas K; Ali HM; Grant K; Savage F; Taylor I; Loizidou M
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):775-82. PubMed ID: 17700263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of endothelin-1 and endothelin-A and -B receptors in invasive bladder cancer.
    Wülfing C; Eltze E; Piechota H; Abol-Enein H; Wülfing P; Bode ME; Hertle L; Sievert KD
    Oncol Rep; 2005 Feb; 13(2):223-8. PubMed ID: 15643502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
    Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
    Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
    Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct patterns of endothelin axis expression in primary prostate cancer.
    Godara G; Pecher S; Jukic DM; D'Antonio JM; Akhavan A; Nelson JB; Pflug BR
    Urology; 2007 Jul; 70(1):209-15. PubMed ID: 17656249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
    Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 and its A and B receptors: are they possibly involved in vitiligo?
    Aly DG; Salem SA; Abdel-Hamid MF; Youssef NS; El Shaer MA
    Acta Dermatovenerol Croat; 2013; 21(1):12-8. PubMed ID: 23683481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer.
    Wülfing P; Kersting C; Tio J; Fischer RJ; Wülfing C; Poremba C; Diallo R; Böcker W; Kiesel L
    Clin Cancer Res; 2004 Apr; 10(7):2393-400. PubMed ID: 15073116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of endothelin and its receptors to ouabain-induced hypertension in rats].
    Jiang X; Guo N; Lü ZR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1297-300. PubMed ID: 16982439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Wülfing P; Tio J; Kersting C; Sonntag B; Buerger H; Wülfing C; Euler U; Boecker W; Tulusan AH; Kiesel L
    Br J Cancer; 2004 Aug; 91(3):434-40. PubMed ID: 15226779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.